InvestorsHub Logo
Followers 0
Posts 25
Boards Moderated 0
Alias Born 03/17/2014

Re: None

Wednesday, 08/23/2017 7:51:49 PM

Wednesday, August 23, 2017 7:51:49 PM

Post# of 703658
I spoke with Les Goldman today. I asked whether he would confirm that the company would report out when they hit 233 OS events or was it the intent to run the trial beyond the 233 events (as some on this board have speculated). I thought he could tell me their intent as I was not asking if they hit 233, but whether they plan on telling us promptly once they do.

You would be right if you guessed that he said he could not disclose that to me as an individual and that such information would have to be reported more broadly to all investors.

He did remark how he was amazed at the shareholders who have called him essentially asking that the company 'speed up the deaths' to get to the 233! He made the obvious comment that patients are living longer and that is only good news. He did not say this directly BUT it sounded like they had not hit 233 OS events yet!

At any rate, he volunteered that if I read the 10Q carefully I would see that they have cash for about 5 months at a burn rate of $1M a month (Les said they brought their burn rate down to $1M per month). He made the point that in the next 5 months he thought that was sufficient to end the trial, start the UCLA and Germany trials and complete the publishing of their paper--he referred to these collective events as an inflection point for the company.

He was very cordial and professional. I found him to be credible.

Holding LONG with 80,000 shares at a $1.52 average.

Good Luck to All




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News